We tested the hypothesis that the MLXIPL rs3812316 variant predicts plasma triglyceride (TG) levels. We compared three groups of adult individuals: 162 persons with TG > 10 mmol/L, 266 persons with TG < 0.65 mmol/L, and 2,043 population-based controls (range of TG concentrations 0.7-8.7 mmol/L). We found a small difference in the frequency of the Gln allele carriers between population controls (20.4%) and persons with low TG (26.3%, P = 0.033). We found no difference between individuals with high TG and population controls, and there was no association between the MLXIPL variant and plasma TG levels among the population controls.

3rd Internal Department 1st Medical Faculty Charles University Prague Czech Republic

Zobrazit více v PubMed

Nat Genet. 2008 Feb;40(2):189-97 PubMed

J Hypertens. 2004 Aug;22(8):1479-85 PubMed

Nat Genet. 2008 Feb;40(2):161-9 PubMed

Circulation. 2007 Jan 30;115(4):450-8 PubMed

BMC Public Health. 2006 Oct 18;6:255 PubMed

Cell Metab. 2006 Aug;4(2):107-10 PubMed

Nat Genet. 2008 Feb;40(2):149-51 PubMed

J Biol Chem. 2006 Sep 29;281(39):28721-30 PubMed

Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?

The Gene Score for Predicting Hypertriglyceridemia: New Insights from a Czech Case-Control Study

Rs6922269 marker at the MTHFD1L gene predict cardiovascular mortality in males after acute coronary syndrome